Medicare Enrolled

Dr. Nicholas Roy, D.O.

Pulmonary Disease · Cherry Hill, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
107 BERLIN ROAD, Cherry Hill, NJ 08034
8564291800
Registered in NPPES since 2010
NPI: 1619288073 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Roy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Roy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Roy

Dr. Nicholas Roy is a pulmonary disease specialist in Cherry Hill, NJ, with 16 years of NPI registration. Based on federal Medicare data, Dr. Roy performed 2,012 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Roy received a total of $5,409 from 34 pharmaceutical and/or device companies across 363 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Roy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years of NPI registration ▲ Top 35% volume in NJ $5,409 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
2,012
Medicare services
Top 35% in NJ for pulmonary disease
Not available
Unique patients (not deduplicated)
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
558 $101 $284
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
429 $66 $162
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
332 $101 $244
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
231 $181 $596
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
132 $145 $430
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
80 $50 $185
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
76 $38 $145
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
68 $23 $120
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
33 $34 $200
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
32 $111 $291
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
27 $144 $365
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
14 $66 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,409
Total received (2018-2024)
Avg $773/year across 7 years
Top 27% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
363
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,390
2023
$983
2022
$1,034
2021
$665
2020
$383
2019
$699
2018
$254

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$274
GlaxoSmithKline, LLC.
$266
GENZYME CORPORATION
$182
Mylan Specialty L.P.
$88
SANOFI-AVENTIS U.S. LLC
$79
Takeda Pharmaceuticals U.S.A., Inc.
$62
Electromed, Inc.
$57
Genentech USA, Inc.
$50
Amgen Inc.
$49
Philips North America LLC
$47
Regeneron Healthcare Solutions, Inc.
$47
Insmed, Inc.
$45
Grifols USA, LLC
$32
Resmed Corp
$17
JAZZ PHARMACEUTICALS INC.
$17
Axsome Therapeutics, Inc.
$16
Azurity Pharmaceuticals, Inc.
$16
Actelion Pharmaceuticals US, Inc.
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
United Therapeutics Corporation
$14
Top 3 companies account for 51.9% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,340
AstraZeneca Pharmaceuticals LP
$1,047
GENZYME CORPORATION
$462
Regeneron Healthcare Solutions, Inc.
$422
Boehringer Ingelheim Pharmaceuticals, Inc.
$289
Mylan Specialty L.P.
$216
Amgen Inc.
$207
SANOFI-AVENTIS U.S. LLC
$156
Philips Electronics North America Corporation
$145
Genentech USA, Inc.
$131
Grifols USA, LLC
$126
Electromed, Inc.
$112
Insmed, Inc.
$100
Actelion Pharmaceuticals US, Inc.
$87
Takeda Pharmaceuticals U.S.A., Inc.
$78
Novartis Pharmaceuticals Corporation
$70
Sunovion Pharmaceuticals Inc.
$47
Philips North America LLC
$47
Teva Pharmaceuticals USA, Inc.
$39
Resmed Corp
$34
JAZZ PHARMACEUTICALS INC.
$32
United Therapeutics Corporation
$31
Advanced Respiratory, Inc
$26
Baxter Healthcare
$22
Inogen, Inc.
$17
Axsome Therapeutics, Inc.
$16
Pulmonx Corporation
$16
Azurity Pharmaceuticals, Inc.
$16
Pharming Healthcare, Inc.
$15
IDORSIA PHARMACEUTICALS US INC
$14
Mallinckrodt Enterprises LLC
$13
Circassia Pharmaceuticals Inc
$12
Bayer HealthCare Pharmaceuticals Inc.
$12
PFIZER INC.
$11
Top 3 companies account for 52.7% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · Adempas · AirDuo Digihaler · Arikayce · Astral · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHARTIS CATHETER · DUPIXENT · ELIQUIS · Esbriet · FASENRA · HORIZANT · Hillrom - Life 2000 Ventilation System · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · LONHALA MAGNAIR · NUCALA · OFEV · OPSUMIT · ORENITRAM · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · RUCONEST · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Wellcentive Undiv · XOLAIR · XYWAV · Xolair · YUPELRI · Yupelri · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pulmonary disease specialist in Cherry Hill?
Compare pulmonary diseases in the Cherry Hill area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases in nearby ZIP areas
275
County median income
$86,384
Nearest hospital to ZIP centroid (approximate)
WEST JERSEY HOSPITAL
4.7 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Roy is a clinical cardiology specialist, with moderate Medicare volume, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Roy experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Roy performed 558 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Roy receive payments from pharmaceutical companies?
Yes. Dr. Roy received a total of $5,409 from 34 companies across 363 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Roy's costs compare to other pulmonary diseases in Cherry Hill?
Dr. Roy's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Roy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →